Construction time: October 13, 2019 to November 27, 2020
Building area: 33,675㎡
Clean area: 27,000 ㎡
Product features: The products involved are high-end raw APIs and innovative preparations for anti-tumor and tumor diagnosis, anti-infection, analgesia, cardiovascular, diabetes and anti-allergy etc.
Scope of contracting: General contracting of construction
Project highlights:Anqing Puli International High-end APIs and Innovative Preparation Manufacturing Base Project covers an area of about 186 mu. The total investment for the project is RMB 500 million. The high-end APIs and innovative preparations are built and produced according to GMP standards of the United States, the European Union and China. It mainly builds production workshops (including 5 API workshops and 1 anti-tumor oral solid preparation workshop) and other infrastructure (including complex building, canteen and shift dormitory, sewage treatment facilities and other auxiliary facilities). Its main products series shall include anti-allergic drugs, antiviral drugs, digestive drugs, congestive heart failure drugs, anti-tumor drugs, contrast agents, polypeptides and upon the completion, the production scale of APIs will reach 360 tons per year.
Upon the completion, this project will be deemed as the first pharmaceutical manufacturing project in Anhui Province in line with the standards of China, the United States and Europe, as well as the largest integration project of international high-end APIs and preparations (chemical drugs) that is in line with international practices in terms of safety, environmental protection, GMP and product certification etc.
Aerial view
Real shots of exterior view